Optimization of Hemodynamic Conditions During Caesarean Section Under Spinal Anaesthesia
NCT ID: NCT01278238
Last Updated: 2013-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2010-01-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that the Phenylephrine model is superior to lower limb compression in preventing hypotension.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemodynamic Measurements During Cesarean Section With Spinal Anesthesia
NCT00199784
Norepinephrine in Caesarian Section
NCT05264870
Hemodynamic Effects of Low Dose Spinal Anesthesia for Cesarean Section
NCT02036697
Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery
NCT03702400
Ephedrine Versus Phenylephrine for Spinal Block - Related Hypotension in Cesarean Delivery
NCT06741410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phenylephrine
Phenylephrine
Intravenous infusion Dosage 0,25 microgram/kg bodyweight as bolus, continuous infusion with 0,25 microgram/kg/min
Lower limb compression
Lower limb compression
Tight bandaging of lower extremity up to hips with compression bandages
Placebo
Placebo
Neither phenylephrine nor lower limb bandaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phenylephrine
Intravenous infusion Dosage 0,25 microgram/kg bodyweight as bolus, continuous infusion with 0,25 microgram/kg/min
Lower limb compression
Tight bandaging of lower extremity up to hips with compression bandages
Placebo
Neither phenylephrine nor lower limb bandaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Heart or vascular disease Cerebrovascular disease Other somatic or psychiatric disease Hypertension or preeclampsia Contraindication against spinal anaesthesia Anomalities concerning pregnancy and foster
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anestesiavdelingen Baerum Sykehus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jana Christine Kuhn
Dr.med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jana Christine Kuhn, Dr.med.
Role: PRINCIPAL_INVESTIGATOR
Bærum sykehus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bærum Sykehus
Rud, Akershus, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-013025-42
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.